One in five Medicare patients return to the hospital within a month after discharge, so it isn’t surprising that the federal government is pushing forward an agenda to discourage costly readmissions. This upcoming October, hospitals with chronic readmission problems with patients struggling with heart failure, pneumonia and heart attack will face Medicare reimbursement penalties.

An Elsevier news brief is stressing the need for a business case for evidence-based medicine (EBM) to improve the U.S. healthcare system. The brief culminated from a roundtable discussion of healthcare industry thought leaders at the CMIO Leadership Forum in Chicago last fall.

The holy grail of modern medicine is better heath and better healthcare at a lower cost--the so-called ‘Triple Aim’--but how far along is the United States on its journey? The latest issue of Health Affairs delves into practices from other countries and lessons the United States could absorb as it sets out to accomplish this triple pursuit.  

When it comes to healthcare, is Kaiser Permanente the wave of the future? The all-in-one hospital system epitomizes well-coordinated patient care and is ahead of the curve in embracing cutting-edge health IT, but can the system ultimately lower costs?

An increasing number of factors thwart efforts to bring new technologies to patients suffering from cardiovascular disease. In the minds of physician researchers and industry leaders, regulatory barriers, less financial return on investment and government impediments interfere with innovation. However, if innovators can adapt and evolve to a more global healthcare ecosystem, a silver lining may materialize.